These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 36933893)
1. Access to legal cannabis market in Canada over the four years following non-medical cannabis legalisation. Myran DT; Friesen EL; Dickson S; Konikoff L; Arora G; Tanuseputro P Drug Alcohol Rev; 2023 Jul; 42(5):1114-1119. PubMed ID: 36933893 [TBL] [Abstract][Full Text] [Related]
2. How has access to legal cannabis changed over time? An analysis of the cannabis retail market in Canada 2 years following the legalisation of recreational cannabis. Myran DT; Staykov E; Cantor N; Taljaard M; Quach BI; Hawken S; Tanuseputro P Drug Alcohol Rev; 2022 Feb; 41(2):377-385. PubMed ID: 34250645 [TBL] [Abstract][Full Text] [Related]
3. Changes in health harms due to cannabis following legalisation of non-medical cannabis in Canada in context of cannabis commercialisation: A scoping review. Myran DT; Imtiaz S; Konikoff L; Douglas L; Elton-Marshall T Drug Alcohol Rev; 2023 Feb; 42(2):277-298. PubMed ID: 36165188 [TBL] [Abstract][Full Text] [Related]
4. Legal cannabis market shares during Canada's first year of recreational legalisation. Armstrong MJ Int J Drug Policy; 2021 Feb; 88():103028. PubMed ID: 33221614 [TBL] [Abstract][Full Text] [Related]
5. Availability, retail price and potency of legal and illegal cannabis in Canada after recreational cannabis legalisation. Mahamad S; Wadsworth E; Rynard V; Goodman S; Hammond D Drug Alcohol Rev; 2020 May; 39(4):337-346. PubMed ID: 32291811 [TBL] [Abstract][Full Text] [Related]
6. Geographic clustering of cannabis stores in Canadian cities: A spatial analysis of the legal cannabis market 4 years post-legalisation. Friesen EL; Konikoff L; Dickson S; Myran DT Drug Alcohol Rev; 2024 Nov; 43(7):1753-1763. PubMed ID: 38803128 [TBL] [Abstract][Full Text] [Related]
7. Access to cannabis retail stores across Canada 6 months following legalization: a descriptive study. Myran DT; Brown CRL; Tanuseputro P CMAJ Open; 2019; 7(3):E454-E461. PubMed ID: 31409593 [TBL] [Abstract][Full Text] [Related]
8. Distribution of legal retail cannabis stores in Canada by neighbourhood deprivation. Fataar F; Driezen P; Owusu-Bempah A; Hammond D J Cannabis Res; 2024 Feb; 6(1):5. PubMed ID: 38351142 [TBL] [Abstract][Full Text] [Related]
9. Relationships between increases in Canadian cannabis stores, sales, and prevalence. Armstrong MJ Drug Alcohol Depend; 2021 Nov; 228():109071. PubMed ID: 34592703 [TBL] [Abstract][Full Text] [Related]
10. Proximity to Legal Cannabis Stores in Canada and Use of Cannabis Sources in the First Three Years of Legalization, 2019-2021. Wadsworth E; Driezen P; Dilley JA; Gabrys R; Jesseman R; Hammond D J Stud Alcohol Drugs; 2023 Nov; 84(6):852-862. PubMed ID: 37306374 [TBL] [Abstract][Full Text] [Related]
11. Cannabis Retail Market Indicators in Five Legal States in the United States: A Public Health Perspective. Dilley JA; Johnson JK; Colby AM; Sheehy TJ; Muse EJ; Filley JR; Segawa MB; Schauer GL; Kilmer B Clin Ther; 2023 Aug; 45(8):778-786. PubMed ID: 37455228 [TBL] [Abstract][Full Text] [Related]
12. Cannabis legalisation: should doctors be concerned? Kanniah G; Kumar S N Z Med J; 2021 Jun; 134(1537):84-90. PubMed ID: 34239164 [TBL] [Abstract][Full Text] [Related]
13. The association between physical availability of cannabis retail outlets and frequent cannabis use and related health harms: a systematic review. Cantor N; Silverman M; Gaudreault A; Hutton B; Brown C; Elton-Marshall T; Imtiaz S; Sikora L; Tanuseputro P; Myran DT Lancet Reg Health Am; 2024 Apr; 32():100708. PubMed ID: 38486811 [TBL] [Abstract][Full Text] [Related]
14. Perceived access to cannabis and ease of purchasing cannabis in retail stores in Canada immediately before and one year after legalization. Wadsworth E; Driezen P; Chan G; Hall W; Hammond D Am J Drug Alcohol Abuse; 2022 Mar; 48(2):195-205. PubMed ID: 35157544 [No Abstract] [Full Text] [Related]
15. Interrupted time series analysis of Canadian legal cannabis sales during the COVID-19 pandemic. Armstrong MJ; Cantor N; Smith BT; Jesseman R; Hobin E; Myran DT Drug Alcohol Rev; 2022 Jul; 41(5):1131-1135. PubMed ID: 35316855 [TBL] [Abstract][Full Text] [Related]
16. Patterns of problematic cannabis use in Canada pre- and post-legalisation: Differences by neighbourhood deprivation, individual socioeconomic factors and race/ethnicity. Fataar F; Driezen P; Owusu-Bempah A; Hammond D Drug Alcohol Rev; 2023 Sep; 42(6):1534-1546. PubMed ID: 37137866 [TBL] [Abstract][Full Text] [Related]
17. Social and public health implications of the legalisation of recreational cannabis: A literature review. Mokwena K Afr J Prim Health Care Fam Med; 2019 Nov; 11(1):e1-e6. PubMed ID: 31793317 [TBL] [Abstract][Full Text] [Related]
18. Relationships between sales of legal medical cannabis and alcohol in Canada Armstrong MJ Health Policy; 2023 Feb; 128():28-33. PubMed ID: 36443110 [TBL] [Abstract][Full Text] [Related]
19. Le marché légal du cannabis suite à sa légalisation au Canada : pistes de réflexion pour un encadrement efficace. Patenaude C; Brochu S; Fallu JS; Jutras-Aswad D; D'Arcy L Can J Public Health; 2018 Apr; 109(2):215-218. PubMed ID: 29981041 [TBL] [Abstract][Full Text] [Related]
20. Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada. Myran DT; Roberts R; Pugliese M; Taljaard M; Tanuseputro P; Pacula RL JAMA Netw Open; 2022 Sep; 5(9):e2231937. PubMed ID: 36112372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]